4-butyrolactone has been researched along with fumarates in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, JX; Hajra, S; Ji, J; Liu, P; Sibi, MP | 1 |
Bambagiotti-Alberti, M; Bartolucci, G; Frediani, M; Frediani, P; Rosi, L | 1 |
Areche, C; Caballero, L; Cartagena, C; Cornejo, A; González, C; Melo, F | 1 |
3 other study(ies) available for 4-butyrolactone and fumarates
Article | Year |
---|---|
Free-radical-mediated conjugate additions. Enantioselective synthesis of butyrolactone natural products: (-)-enterolactone, (-)-arctigenin, (-)-isoarctigenin, (-)-nephrosteranic acid, and (-)-roccellaric acid.
Topics: 4-Butyrolactone; Alkylation; Biological Products; Catalysis; Chemistry, Organic; Free Radicals; Fumarates; Furans; Lactones; Lignans; Magnetic Resonance Spectroscopy; Molecular Structure; Stereoisomerism; Succinates | 2002 |
A convenient route to the synthesis of isotopomeric dihydro-2(3H)furanones.
Topics: 4-Butyrolactone; Deuterium; Fumarates; Furans; Isotope Labeling; Lignans; Maleates; Ruthenium; Succinic Acid | 2007 |
The Fumarprotocetraric Acid Inhibits Tau Covalently, Avoiding Cytotoxicity of Aggregates in Cells.
Topics: 4-Butyrolactone; Antarctic Regions; Ascomycota; Cell Line, Tumor; Fumarates; Humans; Lichens; Neurodegenerative Diseases; Parmeliaceae; Protein Aggregates; tau Proteins; Tauopathies | 2021 |